The dominos are starting to fall for ASX listed Medical Cannabis upstart MGC Pharma, with its third regulatory approval in 3 months being granted. The company will now have the right to market its unique medical cannabis based cosmetic line known as “MGC Derma” into the $1.9b a year Canadian market after the Canadian regulatory authority, Health Canada approved the product.
30/05/2016 - 21:34
MGC Pharma to enter Canadian market with cannabis cosmetics
By Matt Birney
30/05/2016 - 21:34
Related Data & Insights
-
-
Rank Company Revenue th Argent BioPharma $1.7m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
07 Jun 2023
Board Moves May 31 to June 2, 2023
01 Mar 2023
Board Moves March 1, 2023
03 Jan 2023
Board Moves January 3, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX